FeiginVLBraininMNorrvingB, et al. World Stroke Organization: global stroke fact sheet 2025. Int J Stroke2025; 20: 132–144.
2.
Parry-JonesARKrishnamurthiRZiaiWC, et al. World Stroke Organization (WSO): global intracerebral hemorrhage factsheet 2025. Int J Stroke2025; 20: 145–150.
3.
EvansNRPinhoJBeishonL, et al. Frailty and stroke: global implications for assessment, research, and clinical care—a WSO scientific statement. Int J Stroke2025; 20: 905–917.
4.
BoschJLotlikarRMelifonwuR, et al. Prehospital stroke care in low- and middle-income countries: a World Stroke Organization (WSO) scientific statement. Int J Stroke2025; 20: 918–927.
5.
RantaAHartMDos SantosA, et al. Stroke care in indigenous populations: a World Stroke Organization (WSO) scientific statement. Int J Stroke2025; 20: 928–948.
6.
SposatoLACameronACJohansenMC, et al. Ischemic stroke prevention in patients with atrial fibrillation and a recent ischemic stroke, TIA, or intracranial hemorrhage: a World Stroke Organization (WSO) scientific statement. Int J Stroke2025; 20: 385–400.
7.
CordonnierCKlijnCSmithEE, et al. Diagnosis and management of cerebral amyloid angiopathy: a scientific statement from the International CAA association and the World Stroke Organization. Int J Stroke2025; 20: 949–967.
8.
HepworthLRRoweFJWalkerMF, et al. Post-stroke visual impairment: a systematic literature review of types and recovery of visual conditions. Ophthalmol Res2016; 5: 1–43.
9.
RoweFJBrayshawEBrownM, et al. A randomized controlled trial of scanning eye trAining as a rehabilitation choice for hemianopia after stroke (SEARCH). Int J Stroke2025; 20: 968–976.
10.
LiuHLiuKZhangK, et al. Early neurological deterioration in patients with acute ischemic stroke: a prospective multicenter cohort study. Ther Adv Neurol Disord2023; 16: 17562864221147743.
11.
WerringDJOzkanHDoubalF, et al. Early neurological deterioration in acute lacunar ischemic stroke: Systematic review of incidence, mechanisms, and prospects for treatment. Int J Stroke2025; 20: 7–20.
12.
WangYWangYZhaoX, et al. Clopidogrel with aspirin in acute minor stroke or transient ischemic attack. New Engl J Med2013; 369: 11–19.
13.
JohnstonSCEastonJDFarrantM, et al. Clopidogrel and aspirin in acute ischemic stroke and high-risk TIA. New Engl J Med2018; 379: 215–225.
14.
LiuLWongKSLengX, et al. Dual antiplatelet therapy in stroke and ICAS: subgroup analysis of CHANCE. Neurology2015; 85: 1154–1162.
15.
QiaoYZhaoMWangJ, et al. Stroke etiology was associated with tirofiban efficacy in acute ischemic stroke without endovascular treatment: a pre-specified subgroup analysis of the TREND trial. Int J Stroke2025; 20: 977–986.
16.
OhMSYuK-HLeeB-C, et al. Temporal patterns of occult cancer incidence following acute ischemic stroke: a comparative study by stroke etiology. Int J Stroke2025; 20: 1031–1041.
17.
Erritzøe-JervildMWenstrupJHougaardBHKruuseC.Diagnosing cancer-associated ischemic stroke: a systematic review of hematological biomarkers. Int J Stroke2024; 19: 622–634.
18.
SteinauerFBückePBuffleE, et al. Prevalence of right-to-left shunt in stroke patients with cancer. Int J Stroke2024; 19: 1020–1027.
19.
LeeMJChungJWAhnMJ, et al. Hypercoagulability and mortality of patients with stroke and active cancer: the OASIS-CANCER study. J Stroke2017; 19: 77–87.
20.
ChungJWHwangJKimHJ, et al. Edoxaban for the treatment of hypercoagulability and cerebral thromboembolism associated with cancer: a randomized clinical trial of biomarker targets. Int J Stroke2024; 19: 645–653.
